CLARIVATE PLC
NYSE:CLVT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.1
5.72
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
CLARIVATE PLC
Founded with a vision to transform the vast world of information into a wellspring of actionable insights, Clarivate PLC has curated an impressive journey in the realm of data and analytics. The company emerged as a pivotal player by offering a suite of products and services designed to assist organizations in harnessing the power of data. Specializing in innovation lifecycle management, Clarivate provides crucial insights that fuel research and development across industries, empowering clients to make informed decisions. The firm's expansive portfolio, encompassing brands like Web of Science, Cortellis, and Derwent, stands as a testament to its commitment to delivering high-quality, data-driven solutions.
Clarivate thrives financially by licensing its data-driven platforms and analytics tools, enabling clients to navigate challenges in a data-intensive world. The company's subscription-based model ensures a continuous revenue stream, complimented by its ability to tailor solutions to meet the evolving demands of its diverse clientele. By facilitating access to critical scientific and academic content, providing insights into intellectual property, and enhancing competitive analysis frameworks, Clarivate positions itself not merely as a data provider but as an indispensable partner in the strategic growth of businesses worldwide. The firm's ongoing pursuit of innovation ensures that it remains ahead in a rapidly evolving market, maintaining its role as a key enabler of knowledge-driven success.
Founded with a vision to transform the vast world of information into a wellspring of actionable insights, Clarivate PLC has curated an impressive journey in the realm of data and analytics. The company emerged as a pivotal player by offering a suite of products and services designed to assist organizations in harnessing the power of data. Specializing in innovation lifecycle management, Clarivate provides crucial insights that fuel research and development across industries, empowering clients to make informed decisions. The firm's expansive portfolio, encompassing brands like Web of Science, Cortellis, and Derwent, stands as a testament to its commitment to delivering high-quality, data-driven solutions.
Clarivate thrives financially by licensing its data-driven platforms and analytics tools, enabling clients to navigate challenges in a data-intensive world. The company's subscription-based model ensures a continuous revenue stream, complimented by its ability to tailor solutions to meet the evolving demands of its diverse clientele. By facilitating access to critical scientific and academic content, providing insights into intellectual property, and enhancing competitive analysis frameworks, Clarivate positions itself not merely as a data provider but as an indispensable partner in the strategic growth of businesses worldwide. The firm's ongoing pursuit of innovation ensures that it remains ahead in a rapidly evolving market, maintaining its role as a key enabler of knowledge-driven success.
Revenue Guidance Raised: Clarivate increased its full-year 2025 revenue guidance by $50 million to $2.44 billion at the midpoint due to better-than-expected organic performance, FX tailwinds, and slower decline in disposals.
ACV and Renewal Rate Up: Organic annual contract value (ACV) improved to 1.6%, up 30 bps sequentially, and renewal rates reached 93%, a 100 bps increase year-over-year.
Flat Revenue, Improved Margins: Q3 2025 revenue was $623 million, essentially flat year-over-year; net loss narrowed to $28 million due to fewer non-cash charges and FX gains.
Strong Free Cash Flow: Free cash flow was $115 million in Q3 and $276 million year-to-date, supporting $150 million in share buybacks and $100 million in debt repayment.
AI Product Innovation: The company launched 12 new products and AI-powered features, with a focus on embedding AI in workflows and information services to drive future growth and retention.
Segment Performance: Life Sciences and Academia & Government (A&G) both reported 2% ACV growth, while the IP segment saw stabilization after prior declines.
Strategic Portfolio Actions: Clarivate is exiting transactional book sales and some life sciences data resale markets, with disposals expected to reduce revenue by $90 million this year and over $100 million next year.
Full-Year Outlook Affirmed: The company remains on track to meet its 2025 financial guidance, with expectations for recurring organic growth at the higher end of the range.
